Feedback PLC Update re Bleepa® (1508Q)
17 Octubre 2019 - 1:00AM
UK Regulatory
TIDMFDBK
RNS Number : 1508Q
Feedback PLC
17 October 2019
Feedback plc
Update re Bleepa(R)
Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist medical imaging technology
company, is pleased to provide an update on Bleepa(R) .
The Company is considering a number of potential opportunities
for Bleepa(R) following its launch at the NHS Expo in September
2019. The Company is in advanced discussions with NHS pilot sites
whilst additionally pursuing a number of commercial opportunities
within and outside the NHS, and hopes to commence Bleepa(R) pilot
schemes in the near future.
To date, the Bleepa(R) product has been well received by the
healthcare community and the Company believes that it will enable a
number of healthcare providers to provide faster, safer, more
efficient care. The Company looks forward to providing further
updates in due course.
Tom Oakley, CEO of Feedback plc, said:
"We are very encouraged by the response to Bleepa(R) having
discussed this with senior NHS executives and clinicians at NHS
Expo. The feedback that we have received is that Bleepa(R) clearly
has applications across the healthcare sector, not only in
individual hospital settings but also in community and cross site
clinical settings. We look forward to making further announcements
in relation to Bleepa(R) , in due course."
The Company continues to progress with its strategic review of
TexRAD(R) , a longstanding part of the Feedback portfolio. The
Company hopes to complete the strategic review by the end of the
calendar year.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Rozi Morris / Phillip Marriage feedbackplc@instinctif.com
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa(R) , a new secure, encrypted
medical communication app for clinicians accessible through
smartphones, tablets and desktops that facilitates rapid clinical
messaging and review of medical grade imaging for all members of a
clinical team, directly from a hospital Picture Archiving and
Communications System (PACS). For more information on Bleepa(R) ,
see www.bleepa.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDMFBLTMBIBBFL
(END) Dow Jones Newswires
October 17, 2019 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Feedback (LSE:FDBK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024